ARTICLE | Company News
Napo, Glenmark deal
July 18, 2005 7:00 AM UTC
Napo granted Glenmark rights to develop and commercialize crofelemer to treat pediatric, acute infectious and AIDS-related diarrhea in India and 140 other countries, mainly in the developing world. Na...